Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,884
datasets available to search
ShareScore release 0.9.0
Dataset results
2,884 results for “cancer resistance”
ARTEMIS-003: HS-20093 in Patients With Metastatic Castrate-resistant Prostate Cancer (mCRPC) and Advanced Solid Tumors
ClinicalTrials.gov study NCT06001255. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Feasibility of a Chemotherapy With Docetaxel-Prednisone for Castration-resistant Metastatic Prostate Cancer Elderly Patients
ClinicalTrials.gov study NCT01254513. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer Patients
ClinicalTrials.gov study NCT01276899. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer
ClinicalTrials.gov study NCT06361940. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT01337518. IPD Sharing: Not stated. Countries: 2. Publications: 0.
SHR - A1811 Versus Chemotherapy for Platinum-resistant Recurrent Epithelial Ovarian Cancer
ClinicalTrials.gov study NCT06990503. IPD Sharing: NO. Countries: 1. Publications: 0.
Detecting Metastases by PyL PET/CT in Subjects Starting Enzalutamide for Untreated Castration Resistant Prostate Cancer.
ClinicalTrials.gov study NCT04655365. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Study of Utidelone Plus Fruquintinib Combination Therapy for Platinum-Resistant Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT06973421. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of CART-PSMA-TGFβRDN in Patients With Metastatic Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT04227275. IPD Sharing: NO. Countries: 1. Publications: 0.
PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT02042053. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer
ClinicalTrials.gov study NCT04055649. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PS-341 Plus Carboplatin in Platinum and Taxane Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer
ClinicalTrials.gov study NCT00059618. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Platino-resistance in Ovarian Cancer
ClinicalTrials.gov study NCT03954171. IPD Sharing: Not stated. Countries: 1. Publications: 0.
To Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT03752099. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Incidence of Second Primary Malignancies in Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the US
ClinicalTrials.gov study NCT02788409. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Study on the Efficacy and Safety of Fasudil Hydrochloride Combined With Immunotherapy in the Treatment of Metastatic Castration-resistant Prostate Cancer
ClinicalTrials.gov study NCT07250542. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Real-life Experience in Brazil in Patients With Castration-resistant Prostate Cancer Treated With Olaparib+Abiraterone
ClinicalTrials.gov study NCT06457854. IPD Sharing: YES. Countries: 1. Publications: 0.
Chemotherapy With Whole Body Hyperthermia to Treat Resistant Breast, Endometrial, Cervical and Ovarian Cancers
ClinicalTrials.gov study NCT00178802. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pidnarulex and Talazoparib in Patients With Metastatic Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT05425862. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase II Study of Gemcitabine and Capecitabine for Treatment Resistant, Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT01472770. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.